 | • レポートコード：QFJ1-5990 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、腎臓薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腎臓薬の市場動向 ・企業の競争状況、市場シェア ・腎臓薬の種類別市場規模と予測2016-2027（経口、注射） ・腎臓薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他） ・腎臓薬の北米市場規模2016-2027（アメリカ、カナダ） ・腎臓薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Mylan、Roche Holding、Endo International、Bausch Health Companies、Apotex、Cardinal Health、Fresenius、Dava Pharmaceuticals） ・結論 |
Renal diseases are becoming a significant health issue among the general population. Renal drugs are majorly used for kidney disease treatment.
Market Analysis and Insights: Global Renal Drugs Market
The global Renal Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Renal Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Renal Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Renal Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Renal Drugs market.
Global Renal Drugs Scope and Market Size
Renal Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injections
Segment by Application
Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Mylan
Roche Holding
Endo International
Bausch Health Companies
Apotex
Cardinal Health
Fresenius
Dava Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injections
1.3 Market by Application
1.3.1 Global Renal Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Renal Drugs Market Perspective (2016-2027)
2.2 Renal Drugs Growth Trends by Regions
2.2.1 Renal Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Renal Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Renal Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Renal Drugs Industry Dynamic
2.3.1 Renal Drugs Market Trends
2.3.2 Renal Drugs Market Drivers
2.3.3 Renal Drugs Market Challenges
2.3.4 Renal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Drugs Players by Revenue
3.1.1 Global Top Renal Drugs Players by Revenue (2016-2021)
3.1.2 Global Renal Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Renal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Renal Drugs Revenue
3.4 Global Renal Drugs Market Concentration Ratio
3.4.1 Global Renal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Drugs Revenue in 2020
3.5 Renal Drugs Key Players Head office and Area Served
3.6 Key Players Renal Drugs Product Solution and Service
3.7 Date of Enter into Renal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Drugs Breakdown Data by Type
4.1 Global Renal Drugs Historic Market Size by Type (2016-2021)
4.2 Global Renal Drugs Forecasted Market Size by Type (2022-2027)
5 Renal Drugs Breakdown Data by Application
5.1 Global Renal Drugs Historic Market Size by Application (2016-2021)
5.2 Global Renal Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Renal Drugs Market Size (2016-2027)
6.2 North America Renal Drugs Market Size by Type
6.2.1 North America Renal Drugs Market Size by Type (2016-2021)
6.2.2 North America Renal Drugs Market Size by Type (2022-2027)
6.2.3 North America Renal Drugs Market Size by Type (2016-2027)
6.3 North America Renal Drugs Market Size by Application
6.3.1 North America Renal Drugs Market Size by Application (2016-2021)
6.3.2 North America Renal Drugs Market Size by Application (2022-2027)
6.3.3 North America Renal Drugs Market Size by Application (2016-2027)
6.4 North America Renal Drugs Market Size by Country
6.4.1 North America Renal Drugs Market Size by Country (2016-2021)
6.4.2 North America Renal Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Renal Drugs Market Size (2016-2027)
7.2 Europe Renal Drugs Market Size by Type
7.2.1 Europe Renal Drugs Market Size by Type (2016-2021)
7.2.2 Europe Renal Drugs Market Size by Type (2022-2027)
7.2.3 Europe Renal Drugs Market Size by Type (2016-2027)
7.3 Europe Renal Drugs Market Size by Application
7.3.1 Europe Renal Drugs Market Size by Application (2016-2021)
7.3.2 Europe Renal Drugs Market Size by Application (2022-2027)
7.3.3 Europe Renal Drugs Market Size by Application (2016-2027)
7.4 Europe Renal Drugs Market Size by Country
7.4.1 Europe Renal Drugs Market Size by Country (2016-2021)
7.4.2 Europe Renal Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Renal Drugs Market Size (2016-2027)
8.2 Asia-Pacific Renal Drugs Market Size by Type
8.2.1 Asia-Pacific Renal Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Renal Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Renal Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Renal Drugs Market Size by Application
8.3.1 Asia-Pacific Renal Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Renal Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Renal Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Renal Drugs Market Size by Region
8.4.1 Asia-Pacific Renal Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Renal Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Renal Drugs Market Size (2016-2027)
9.2 Latin America Renal Drugs Market Size by Type
9.2.1 Latin America Renal Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Renal Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Renal Drugs Market Size by Type (2016-2027)
9.3 Latin America Renal Drugs Market Size by Application
9.3.1 Latin America Renal Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Renal Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Renal Drugs Market Size by Application (2016-2027)
9.4 Latin America Renal Drugs Market Size by Country
9.4.1 Latin America Renal Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Renal Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Drugs Market Size (2016-2027)
10.2 Middle East & Africa Renal Drugs Market Size by Type
10.2.1 Middle East & Africa Renal Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Renal Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Renal Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Renal Drugs Market Size by Application
10.3.1 Middle East & Africa Renal Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Renal Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Renal Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Renal Drugs Market Size by Country
10.4.1 Middle East & Africa Renal Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Renal Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Mylan
11.1.1 Mylan Company Details
11.1.2 Mylan Business Overview
11.1.3 Mylan Renal Drugs Introduction
11.1.4 Mylan Revenue in Renal Drugs Business (2016-2021)
11.1.5 Mylan Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Details
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Renal Drugs Introduction
11.2.4 Roche Holding Revenue in Renal Drugs Business (2016-2021)
11.2.5 Roche Holding Recent Development
11.3 Endo International
11.3.1 Endo International Company Details
11.3.2 Endo International Business Overview
11.3.3 Endo International Renal Drugs Introduction
11.3.4 Endo International Revenue in Renal Drugs Business (2016-2021)
11.3.5 Endo International Recent Development
11.4 Bausch Health Companies
11.4.1 Bausch Health Companies Company Details
11.4.2 Bausch Health Companies Business Overview
11.4.3 Bausch Health Companies Renal Drugs Introduction
11.4.4 Bausch Health Companies Revenue in Renal Drugs Business (2016-2021)
11.4.5 Bausch Health Companies Recent Development
11.5 Apotex
11.5.1 Apotex Company Details
11.5.2 Apotex Business Overview
11.5.3 Apotex Renal Drugs Introduction
11.5.4 Apotex Revenue in Renal Drugs Business (2016-2021)
11.5.5 Apotex Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Details
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Renal Drugs Introduction
11.6.4 Cardinal Health Revenue in Renal Drugs Business (2016-2021)
11.6.5 Cardinal Health Recent Development
11.7 Fresenius
11.7.1 Fresenius Company Details
11.7.2 Fresenius Business Overview
11.7.3 Fresenius Renal Drugs Introduction
11.7.4 Fresenius Revenue in Renal Drugs Business (2016-2021)
11.7.5 Fresenius Recent Development
11.8 Dava Pharmaceuticals
11.8.1 Dava Pharmaceuticals Company Details
11.8.2 Dava Pharmaceuticals Business Overview
11.8.3 Dava Pharmaceuticals Renal Drugs Introduction
11.8.4 Dava Pharmaceuticals Revenue in Renal Drugs Business (2016-2021)
11.8.5 Dava Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Renal Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injections
Table 4. Global Renal Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Renal Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Renal Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Renal Drugs Market Share by Regions (2016-2021)
Table 8. Global Renal Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Renal Drugs Market Share by Regions (2022-2027)
Table 10. Renal Drugs Market Trends
Table 11. Renal Drugs Market Drivers
Table 12. Renal Drugs Market Challenges
Table 13. Renal Drugs Market Restraints
Table 14. Global Renal Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Renal Drugs Market Share by Players (2016-2021)
Table 16. Global Top Renal Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Drugs as of 2020)
Table 17. Ranking of Global Top Renal Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Renal Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Renal Drugs Product Solution and Service
Table 21. Date of Enter into Renal Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Renal Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Renal Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Renal Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Renal Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Renal Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Renal Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Renal Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Renal Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Renal Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Renal Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Renal Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Renal Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Renal Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Renal Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Renal Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Renal Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Renal Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Renal Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Renal Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Renal Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Renal Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Renal Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Renal Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Renal Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Renal Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Renal Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Renal Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Renal Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Renal Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Renal Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Renal Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Renal Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Renal Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Renal Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Renal Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Renal Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Renal Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Renal Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Mylan Company Details
Table 62. Mylan Business Overview
Table 63. Mylan Renal Drugs Product
Table 64. Mylan Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 65. Mylan Recent Development
Table 66. Roche Holding Company Details
Table 67. Roche Holding Business Overview
Table 68. Roche Holding Renal Drugs Product
Table 69. Roche Holding Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 70. Roche Holding Recent Development
Table 71. Endo International Company Details
Table 72. Endo International Business Overview
Table 73. Endo International Renal Drugs Product
Table 74. Endo International Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 75. Endo International Recent Development
Table 76. Bausch Health Companies Company Details
Table 77. Bausch Health Companies Business Overview
Table 78. Bausch Health Companies Renal Drugs Product
Table 79. Bausch Health Companies Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 80. Bausch Health Companies Recent Development
Table 81. Apotex Company Details
Table 82. Apotex Business Overview
Table 83. Apotex Renal Drugs Product
Table 84. Apotex Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 85. Apotex Recent Development
Table 86. Cardinal Health Company Details
Table 87. Cardinal Health Business Overview
Table 88. Cardinal Health Renal Drugs Product
Table 89. Cardinal Health Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 90. Cardinal Health Recent Development
Table 91. Fresenius Company Details
Table 92. Fresenius Business Overview
Table 93. Fresenius Renal Drugs Product
Table 94. Fresenius Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 95. Fresenius Recent Development
Table 96. Dava Pharmaceuticals Company Details
Table 97. Dava Pharmaceuticals Business Overview
Table 98. Dava Pharmaceuticals Revenue in Renal Drugs Business (2016-2021) & (US$ Million)
Table 99. Dava Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injections Features
Figure 4. Global Renal Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Renal Drugs Report Years Considered
Figure 11. Global Renal Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Renal Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Renal Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Renal Drugs Market Share by Regions (2022-2027)
Figure 15. Global Renal Drugs Market Share by Players in 2020
Figure 16. Global Top Renal Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Renal Drugs Revenue in 2020
Figure 18. Global Renal Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Renal Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Renal Drugs Market Share by Type (2016-2027)
Figure 22. North America Renal Drugs Market Share by Application (2016-2027)
Figure 23. North America Renal Drugs Market Share by Country (2016-2027)
Figure 24. United States Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Renal Drugs Market Share by Type (2016-2027)
Figure 28. Europe Renal Drugs Market Share by Application (2016-2027)
Figure 29. Europe Renal Drugs Market Share by Country (2016-2027)
Figure 30. Germany Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Renal Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Renal Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Renal Drugs Market Share by Region (2016-2027)
Figure 40. China Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Renal Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Renal Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Renal Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Renal Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Renal Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Renal Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Renal Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Mylan Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 60. Roche Holding Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 61. Endo International Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 62. Bausch Health Companies Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 63. Apotex Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 64. Cardinal Health Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 65. Fresenius Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 66. Dava Pharmaceuticals Revenue Growth Rate in Renal Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年） Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women. Market Analysis and Insights: Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market The glo…- 世界の腎疾患治療薬市場規模・現状・予測（2021年-2027年） Kidney disease commonly referred to as kidney disease or kidney disease, mainly manifested as abnormal urine volume, urination abnormalities, lumbago.Kidney disease drugs include blood pressure drugs, anti-hyperlipidemia drugs, erythropoietics (ESA), diuretics and so on. Market Analysis and Insights…
- 末期腎不全（ESRD）薬のグローバル市場調査 2019年 The global End-Stage Renal Disease (ESRD) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on End-Stage Renal Disease (ESRD) Drugs volume and value at global level, regional level and company leve…
- 世界の腎嚢胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Renal Cyst Treatment Market The global Renal Cyst Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の腎臓バイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Renal Biomarker Market The global Renal Biomarker market size is projected to reach US$ 1270.4 million by 2027, from US$ 964.4 million in 2020, at a CAGR of 4.0% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…